Wellgistics health reports strong q1 operational growth across manufacturer, product, and pharmacy expansion with over 350 new pharmacies added to its nationwide network

Tampa, fl / access newswire / april 30, 2025 / wellgistics health, inc. (nasdaq:wgrx) ("wellgistics health"), a holding company for various existing and planned strategic businesses centered around healthcare technology and pharmaceutical services, today announced key unaudited operational performance highlights for the first quarter of 2025, signaling continued acceleration across its national platform. some of wellgistics health's q1 2025 operational highlights include: 354 new independent pharmacies added 22 new pharmaceutical manufacturers onboarded 57 new prescription drug products integrated into the portfolio "these numbers are a clear signal the industry is demanding change," said brian norton, ceo of wellgistics health.
WGRX Ratings Summary
WGRX Quant Ranking